Tertiary Lymphoid Structure Was a Predictor of Favorable Prognosis in Muscle-invasive Bladder Cancer

被引：0
|
作者：
Teng, Xiaodong [1 ]
Chen, Zhen [1 ]
Bai, Yanfeng [2 ]
Cao, Hui [1 ]
Zhang, Jing [1 ]
Xu, Liming [1 ]
Liu, Kaihua
Shi, Yuqian
Shao, Yang
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Beijing, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
847
引用
收藏
页码：S1063 / S1063
页数：1
相关论文
共 50 条
  • [21] Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer
    Kageyama, Y
    Yokoyama, M
    Sakai, Y
    Saito, K
    Koga, F
    Yano, M
    Arai, G
    Hyochi, N
    Masuda, H
    Fujii, Y
    Kawakami, S
    Kobayashi, T
    Kihara, K
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (05): : 504 - 507
  • [22] A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
    Wang, Weizhuo
    Zhang, Xi
    Jiang, Silin
    Xu, Peng
    Chen, Kang
    Li, Kai
    Wang, Fei
    Le, Xiang
    Zhang, Ke
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] MOLECULAR PREDICTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND PROGNOSIS IN MUSCLE-INVASIVE BLADDER CANCER
    Ragonese, Mauro
    Di Gianfrancesco, Luca
    Schinzari, Giovanni
    Palermo, Giuseppe
    Racioppi, Marco
    Bassi, PierFrancesco
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1024 - E1025
  • [24] Bladder sparing options for muscle-invasive bladder cancer
    Laukhtina, Ekaterina
    Moschini, Marco
    Teoh, Jeremy Yuen-Chun
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2024, 34 (06) : 471 - 476
  • [25] Bladder preserving strategies for muscle-invasive bladder cancer
    Merseburger, Axel S.
    Matuschek, Ira
    Kuczyk, Markus A.
    CURRENT OPINION IN UROLOGY, 2008, 18 (05) : 513 - 518
  • [26] Intratumoral CCR5+neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses
    Xiang, Zhuoyi
    Zhou, Quan
    Zeng, Han
    Wang, Zewei
    Zhang, Hongyu
    Liu, Zhaopei
    Huang, Qiuren
    Chang, Yuan
    Bai, Qi
    Xia, Yu
    Wang, Yiwei
    Liu, Li
    Zhu, Yu
    Xu, Le
    Dai, Bo
    Wang, Jiajun
    Guo, Jianming
    Xu, Jiejie
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [27] Management and prognosis of TCC superficial recurrence in muscle-invasive bladder cancer after bladder preservation
    Palou, J
    Pieras, E
    Rosales, A
    Huguet, J
    Salvador, J
    Marcuello, E
    Villavicencio, H
    JOURNAL OF UROLOGY, 2003, 169 (04): : 226 - 226
  • [28] Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer
    Ahmed M. Mansour
    Mona Abdelrahim
    Mahmoud Laymon
    Mamdouh Elsherbeeny
    Mohammed Sultan
    Ahmed Shokeir
    Ahmed Mosbah
    Hassan Abol-Enein
    Amira Awadalla
    Eunho Cho
    Vikram Sairam
    Taeeun D. Park
    Muhammad Shahid
    Jayoung Kim
    BMC Urology, 18
  • [29] Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer
    Amisha Singh
    Appledene S. Osbourne
    Vadim S. Koshkin
    Current Treatment Options in Oncology, 2023, 24 (9) : 1213 - 1230
  • [30] Managing muscle-invasive bladder cancer in the elderly
    Weizer, Alon Z.
    Palella, Gaetano V.
    Montgomery, Jeffrey S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (06) : 903 - 915
12345